01 · THE CUSTOMER PROBLEM
Using chitosan as an active requires a defined function, dose and regulatory pathway—not a general claim that the polymer is bioactive.
Mykito isolates the target function—hemostatic, antimicrobial, bioadhesive or film-forming—then engineers charge density, MW, purity and format around the required test.
Chitosan can contribute intrinsic function—not only structure—when its molecular specification is aligned with the formulation.
02 · RECOMMENDED STARTING POINT
Start with the material designed for the decision.
Mykito engineers charge density, molecular weight and solubility so development teams can evaluate chitosan as the functional component responsible for a defined product effect.
Without the shell
Controlled fungal sourcing supports a traceable, non-animal supply strategy.
Specification engineered
MW, DDA, purity, charge density and format are selected around the target result.
Application ready
Powder is only the starting point; Mykito also develops films, fibers, gels, coatings and formulations.
One technical partner
Material selection, formulation support and the validation plan are connected from the first sample.
03 · PERFORMANCE TARGETS
Build toward outcomes a buyer can measure.
Hemostatic function
Cationic interaction with blood components supports development of materials intended to promote clot formation.
Antimicrobial function
Charge, MW, DDA, pH and formulation conditions can be optimized around antimicrobial-performance studies.
Bioadhesion
Polymer-surface interactions can increase residence time and help retain a formulation where it is applied.
Film-forming activity
A continuous chitosan layer can create a protective, breathable or active surface in the finished product.
04 · GO / NO-GO CRITERIA
Define the evidence before testing begins.
The first program is designed around three decision-making outputs—not an open-ended material trial.
Function-specific dose response
Safety and finished-form compatibility
Claim substantiation and regulatory classification
05 · FROM SAMPLE TO DECISION
A practical application program,
not a bag of powder.
Define
Agree on the function, baseline, constraints and measurable success criteria.
Screen
Select the MW, DDA, purity, dose and physical format that fit the application.
Validate
Test the winning system in the finished formulation, device, process or use environment.
Recommended first request: A function-matched ChitoGene or BioFoundry grade selected after technical scoping.
Start the Sample Brief06 · WHY CHITOSAN
Cationic complexation + matrix control
Protonated amino groups can interact with selected anionic actives, polymers and biological surfaces. MW, DDA, crosslinking and architecture then provide levers for adhesion, protection and release.
There is no universal concentration. Grade and dose are screened against pH, interacting ingredients, process conditions and the target performance profile.
Route-specific purity, residuals, compatibility, stability and regulatory suitability are established for the finished system.